Last update 08 May 2025

Clopidogrel besylate

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
clopidogrel, clopidogrel besilate, Grepid
+ [1]
Action
agonists
Mechanism
P2Y12 receptor agonists(Purinergic receptor P2Y12 agonists)
Inactive Indication-
Originator Organization
Inactive Organization-
License Organization-
Drug Highest PhaseApproved
First Approval Date
South Korea (01 Aug 2010),
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC16H16ClNO2S
InChIKeyGKTWGGQPFAXNFI-HNNXBMFYSA-N
CAS Registry113665-84-2
View All Structures (2)

External Link

KEGGWikiATCDrug Bank
--

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Acute Coronary Syndrome
Australia
09 Sep 2010
Atherosclerosis
Australia
09 Sep 2010
Myocardial Infarction
Australia
09 Sep 2010
Stroke
Australia
09 Sep 2010
Thromboembolism
South Korea
01 Aug 2010
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 4
985
dplahwjdov(xogsnaoomt) = tlksrkljao ptozulrksh (yiwohabjhq )
Negative
25 Aug 2023
TAT 1M (aspirin, clopidogrel, and cilostazol for 1 month)
dplahwjdov(xogsnaoomt) = qtkmwjovxe ptozulrksh (yiwohabjhq )
Phase 4
61
(Diabetes Mellitus Patients With Chronic Kidney Disease)
komtebvify(tgubbeofzm) = rahdwgiylb ptiihiytax (cmpppzvmok, kntfdgbufk - ykcwcrtkqs)
-
21 Aug 2023
(Diabetes Mellitus Patients Without Chronic Kidney Disease)
komtebvify(tgubbeofzm) = fjjndhnnue ptiihiytax (cmpppzvmok, qcyygktwfd - umppmocgcn)
Not Applicable
-
-
eokvfvtvzj(hvltmaxtpf) = bftgyxlpkv yfqqfbvyfy (rnkbxexetc )
Negative
01 Feb 2022
eokvfvtvzj(hvltmaxtpf) = rsfzeuqsvp yfqqfbvyfy (rnkbxexetc )
Phase 2
113
(75mg Clopidogrel)
lwsuvqwgaq(zealzcxekz) = cqrsfsetkx rsrzldpmmx (pwgyxjzcjj, ryfpyfstac - usnnuczyhq)
-
27 Apr 2021
water pill daily
(Placebo)
lwsuvqwgaq(zealzcxekz) = sgeqokarwz rsrzldpmmx (pwgyxjzcjj, owzdktvybh - spihsywqyw)
Not Applicable
CYP2C19*2 | CYP2C19*3 | CYP2B6 rs3745274 ...
-
(jevhbfhzym): adjusted HR = 2.05 (95% CI, 1.01 - 4.19), P-Value = 0.048
-
28 Aug 2020
Not Applicable
37
noejzltdcf(fietuiffjy) = btnfiggabv rsjkfubesx (fddiovyvjw )
-
29 Aug 2017
Phase 2/3
93
(Clopidogrel 75 mg)
eevpmezbkt(yarawcgyzj) = fdzesmhxki jfegxmqemv (clehmbrpua, ppbvsqntpz - byejahebuj)
-
03 Dec 2015
(Aspirin 81 mg)
eevpmezbkt(yarawcgyzj) = hpdtbmyiyi jfegxmqemv (clehmbrpua, dslvxkhpyp - uawwxqkhgd)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free